Online Only
The welcome remarks are not accredited for continuing education.
Speaker(s):Breaks and Q&A are not accredited for continuing education.
Speaker(s):Lunch is provided for on-site attendees.
This symposium is not provided for CME.
"Long-Haul COVID is our calling and we should take the lead" - Avindra Nath, MD 2020, Editorial, American Academy of Neurology
Even mild COVID-19 infection may lead to persistent and potentially incapacitating clinical manifestations (Postacute Sequelae of SARS-CoV-2 Infection (PASC)).
More than half of COVID-19 survivors experienced PASC 6 months after recovery. It is estimated that anywhere from 10% to 30% of patients might experience long COVID after recovering.
Among pain-related symptoms, chest pain, headaches, arthralgia, neuralgia, and abdominal pain are most persistent. Central and peripheral nerve systems are one of the most susceptible targets for SARS-CoV-2 virus. A meta-analysis of pain-related symptoms reported for patients with long-term PASC determined that every one month of follow-up corresponded to a 45% increase in prevalence in patients who developed neuralgia after acute COVID-19 infection.
Among evaluated patients with long COVID, prolonged, often disabling, small-fiber neuropathy after mild SARS-CoV-2 was most common, beginning within 1 month of COVID-19 onset. Various evidence suggested infection-triggered immune dysregulation as a common mechanism. - Nath, 2022
Symptoms of long COVID are reported to be on-and-off, cyclic or multiphasic. A meta-analysis of pain-related symptoms reported for patients with long-term PASC determined that every one month of follow-up corresponded to a 45% increase in prevalence in patients who developed neuralgia after acute COVID-19 infection.
Weakness, often accompanied by myalgia and arthralgia, is a musculoskeletal manifestation of SARS-CoV-2 infection.
Central and peripheral nerve systems are one of the most susceptible targets for SARS-CoV-2 virus (neurotropism).
As well, a prolonged period of mechanical ventilation in the ICU may cause what is called “post intensive care syndrome” or “ICU-acquired weakness”, manifesting as cognitive dysfunction, muscle atrophy, sensory disruption and joint-related pain.
Residual effects from SARS-CoV-2 virus include fatigue, dyspnea, chest pain, persistent loss of taste and/or smell, cognitive changes, arthralgias, and decreased quality of life.
Accreditation & Designation
Neurovations Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Neurovations Education designates this other activity (blended learning) for a maximum of 1.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Accreditation & Designation
Neurovations Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Neurovations Education designates this other activity (blended learning) for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Speaker(s):